Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves

Olasińska-Wiśniewska, Anna; Buczkowski, Piotr; Perek, Bartłomiej; Puslecki, Mateusz; Bociański, Michał; Stefaniak, Sebastian; Urbanowicz, Tomasz; Grygier, Marek; Lesiak, Maciej; Jemielity, Marek

doi:10.5603/cj.a2021.0164

Cited by 1 publication

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The exception was the case of the reoperated patient in whom full femoral retrograde cannulation was performed. After either native or prosthetic valves were removed, sutureless prostheses were implanted as described previously [7]. The further stages of surgery were standard, including an epicardial electrode for pacing and drainage tube implantation.…”

Section: Surgical Detailsmentioning

confidence: 99%

Feasibility of clinical application of Perceval sutureless bioprostheses in emergency patients with unexpected intraoperative findings

Bociański

Puslecki²,

Olasińska-WIśniewska³

et al. 2022

Medical Research Journal

Self Cite

View full text Add to dashboard Cite

Introduction: Sutureless aortic prostheses provide an attractive opportunity for high-risk patients with difficult surgical anatomy of the aortic root.Aim of the study: To assess the outcomes of emergent aortic valve replacement (AVR) with Perceval sutureless bioprostheses in a group of high-risk patients in whom their implantation had not been considered before surgery.Material and methods: Since 2018, 53 sutureless aortic bioprostheses have been implanted in our center.In this single-center retrospective study, 7 high-risk (median EuroSCORE II 9.43%) patients (4 women and 3 men; median age 63 [28 to 73] years) were identified to undergo emergent procedures. They were operated on for active endocarditis on the native valves with extensive destruction of the annulus (n = 4), endocarditis on a previously implanted bioprosthesis (n = 1), organizing thrombus of the mechanical valve (n = 1), and diffuse aortitis (n = 1). Implantation feasibility, as well as postprocedural mortality and morbidity, were evaluated. Results:The following sizes of bioprostheses were used: XL (n = 3); L (n = 2); M (n = 1), and S (n = 1).The median (minimum; maximum) cross-clamping aortic time was 64 (37; 73) minutes while cardiopulmonary bypass time was 86 (49; 188) minutes, respectively. All patients survived operations and the first 30 days. Two of them died in the hospital because of multiorgan failure on 35 th and 45 th postoperative days. The follow-up period ranging from 6 to 40 months was completed by all who were discharged alive.Conclusions: Despite the well-known advantages of sutureless valves, they can be also used successfully in patients in whom standard prosthesis implantation is either impossible or highly demanding, including emergency cases with unexpected intraoperative findings.

show abstract

Section: Surgical Detailsmentioning

confidence: 99%

Feasibility of clinical application of Perceval sutureless bioprostheses in emergency patients with unexpected intraoperative findings

Bociański

Puslecki²,

Olasińska-WIśniewska³

et al. 2022

Medical Research Journal

Self Cite

View full text Add to dashboard Cite

show abstract

Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves

Abstract: This article has been peer reviewed and published immediately upon acceptance.It is an open access article, which means that it can be downloaded, printed, and distributed freely, provided the work is properly cited. Articles in "Cardiology Journal" are listed in PubMed.

Cited by 1 publication

References 9 publications

Feasibility of clinical application of Perceval sutureless bioprostheses in emergency patients with unexpected intraoperative findings

Feasibility of clinical application of Perceval sutureless bioprostheses in emergency patients with unexpected intraoperative findings

Contact Info

Product

Resources

About